Verona Pharma appoints Vikas Sinha as non-executive director
Mr. Sinha has over 20 years of experience working in senior finance roles in the life sciences industry. He is currently Executive Vice President and Chief Financial Officer of Alexion Pharmaceuticals.
He joined Alexion in 2005 and is responsible for global financial management, information technology, corporate and strategic development, treasury, internal audit and investor relations.
Prior to Alexion, Mr. Sinha spent 11 years at Bayer AG where he held various positions within the company in the United States, Canada, Japan and Germany.
His last role was Vice President and Chief Financial Officer of Bayer Pharmaceuticals Corporation, USA, where he was responsible for financial management and strategic planning in North America.
Prior to his time at Bayer AG, Mr. Sinha worked at ANZ Bank as a Senior Manager in Corporate Banking and at Citibank as an analyst.
Mr. Sinha is a chartered accountant by training. He is a certified public accountant in the USA, and an associate member of the Institute of Chartered Accountants of India. He also has a Masters degree in Business Administration from the Asian Institute of Management in the Philippines. ■
LATEST MOVES FROM United Kingdom
- Charles Stanley Group appoints Marcia Campbell as director
- Arix Bioscience appoints Giles Kerr to board
- Crimson Tide appoints Tobias James Turness Hawkins to board
- Silence Therapeutics appoints Annalisa Jenkins to board
- Augean appoints two directors
More inside POST